Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
UT Health scientists discover epigenetic changes that contribute to AML

UT Health scientists discover epigenetic changes that contribute to AML

New trial aims to prolong remission for pediatric leukemia patients treated with T-cell immunotherapy

New trial aims to prolong remission for pediatric leukemia patients treated with T-cell immunotherapy

WHO to launch pilot project for prequalifying biosimilar cancer medicines

WHO to launch pilot project for prequalifying biosimilar cancer medicines

Vitamin A deficiency leads to loss of blood stem cells

Vitamin A deficiency leads to loss of blood stem cells

FDA approves new AML drug after clinical testing at Dana-Farber

FDA approves new AML drug after clinical testing at Dana-Farber

Molecular mechanism reprograms tumor cells to drive treatment resistance in advanced prostate cancer

Molecular mechanism reprograms tumor cells to drive treatment resistance in advanced prostate cancer

Researchers identify key player in initiation and progression of melanoma

Researchers identify key player in initiation and progression of melanoma

Study suggests how existing and emerging immunotherapy treatments could be successful for sarcomas

Study suggests how existing and emerging immunotherapy treatments could be successful for sarcomas

Invivoscribe receives FDA approval for the LeukoStrat CDx FLT3 mutation assay companion diagnostic test for the selection of patients for Rydapt

Invivoscribe receives FDA approval for the LeukoStrat CDx FLT3 mutation assay companion diagnostic test for the selection of patients for Rydapt

Formaldehyde exposure not linked to leukemia, research shows

Formaldehyde exposure not linked to leukemia, research shows

TACC's supercomputers assist in discovery of new, better chemotherapy drugs

TACC's supercomputers assist in discovery of new, better chemotherapy drugs

Scientists launch new virtual platform to aid global search for treatment of leukemia

Scientists launch new virtual platform to aid global search for treatment of leukemia

FDA approves new drug and chemotherapy combination for treatment of adult patients with AML

FDA approves new drug and chemotherapy combination for treatment of adult patients with AML

Gene critical for tumor progression also encourages growth of intestinal stem cells, study shows

Gene critical for tumor progression also encourages growth of intestinal stem cells, study shows

Virtual human simulation can help medical students learn advanced communication skills

Virtual human simulation can help medical students learn advanced communication skills

Scientists announce ‘outstanding’ results of new blood cancer study

Scientists announce ‘outstanding’ results of new blood cancer study

Study finds link between fertility treatments and pediatric tumors

Study finds link between fertility treatments and pediatric tumors

Whole-exome sequencing may routinely miss detecting some disease-causing genes, say researchers

Whole-exome sequencing may routinely miss detecting some disease-causing genes, say researchers

Researchers develop new approach to protect stem cell recipients from graft-versus-host disease

Researchers develop new approach to protect stem cell recipients from graft-versus-host disease

Second cancers are far deadlier in younger people than older adults

Second cancers are far deadlier in younger people than older adults